November 2015 Volume 22 Issue 4

Assessing the Impact of Vessel Centering on Dissolution Results-A Case Study Jian-Hwa Han1, Anagha Vaidya2, Daniel Bonilla1, and Stephen Anderson1 1NCE Analytical R&D, AbbVie Inc, North Chicago, IL USA 2Formulation R&D, Teva Pharmaceuticals, North Wales, PA USA Performance Test for Parenteral Dosage Forms Vinod P. Shah, James DeMuth, and Desmond G. Hunt United States Pharmacopeia, Rockville, MD, USA Design and Evaluation of a Novel Bio-Mimicking In Vitro Dissolution Test Apparatus for Floating Drug Delivery Systems L. Baldaniya1, S. Saisivam2, and M. Gohel1 1Department of Pharmaceutical Technology, Anand Pharmacy College, Gujarat, India 2Department of Pharmaceutical Technology, N. R. Vekaria Institute of Pharmacy, Gujarat, India Effect of Polymorphism and Application of Kinetic Models for the Evaluation of In Vitro Dissolution Profiles of an Eletriptan Hydrobromide Formulation Pavan Kommavarapu1, Arthanareeswari Maruthapillai1, Kamaraj Palanisamy1, and Ravi Teja Koya2 1Department of Chemistry, SRM University, Tamilnadu, India 2Department of Pharmaceutical Analysis, Acharya Nagarjuna University, Guntur, India Comparison of Dissolution Profiles of Commercially Available Lamivudine Tablets Naile Ozturk1,2, Mustafa Sinan Kaynak1, and Selma Sahin2 1Faculty of Pharmacy, Department of Pharmaceutical Technology, Inonu University, Malatya, Turkey 2Faculty of Pharmacy, Department of Pharmaceutical Technology, Hacettepe University, Ankara, Turkey Meeting Report: Profiling of Drug Dissolution, Pharmacokinetics and Pharmacodynamics Vivian A. Gray1 and Kim Huynh-Ba2 1Dissolution Technologies, Hockessin, DE, USA 2Pharmalytik, Newark, DE, USA Question & Answer Section Margareth Marques and William Brown U.S. Pharmacopeia, Rockville, MD, USA